High-activity Natural Killer Immunotherapy for Small Metastases of Non-small Cell Lung Cancer

The requested reference [87702c0c442157f91752a2d2aea18f51de4da4aa] no longer exists in our database. It has been replaced by the current reference: [9e495dab46c7013708c88b2723ea1098ed48fb74]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The aim of this study is the safety and efficacy of high-activity natural killer immunotherapy to small metastases of non-small cell lung cancer.
Epistemonikos ID: e9d1d7f7103c0eb1b65ec8900f26470eb89ca50d
First added on: May 20, 2024